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Abstract: Resonance Raman (RR) studies of intermediates generated by
cryoreduction of the oxyferrous complex of the D251N mutant of cytochrome
P450cam (CYP101) are reported. Owing to the fact that proton delivery to the
active site is hindered in this mutant, the unprotonated peroxo-ferric
intermediate is observed as the primary species after radiolytic reduction of
the oxy-complex in frozen solutions at 77 K. In as much as previous EPR and
ENDOR studies have shown that annealing of this species to ∼180 K results in
protonation of the distal oxygen atom to form the hydroperoxo intermediate,
this system has been exploited to permit direct RR interrogation of the
changes in the Fe−O and O−O bonds caused by the reduction and subsequent
protonation. Our results show that the ν(O−O) mode decreases from a
superoxo-like frequency near ∼1130 cm−1 to 792 cm−1 upon reduction. The
latter frequency, as well as its lack of sensitivity to H/D exchange, is
consistent with heme-bound peroxide formulation. This species also exhibits a
ν(Fe−O) mode, the 553 cm−1 frequency of which is higher than that observed
for the nonreduced oxy P450 precursor (537 cm −1), implying a strengthened
Fe−O linkage upon reduction. Upon subsequent protonation, the resulting
Fe−O−OH fragment exhibits a lowered ν(O−O) mode at 774 cm −1, whereas
the ν(Fe−O) increases to 564 cm−1. Both modes exhibit a downshift upon H/D
exchange, as expected for a hydroperoxo-ferric formulation. These
experimental RR data are compared with those previously acquired for the
wild-type protein, and the shifts observed upon reduction and subsequent
protonation are discussed with reference to theoretical predictions.

Introduction
Activation of molecular oxygen by the heme enzymes such as
the cytochromes P450, nitric oxide synthase, and heme oxygenase
represents a sequence of coordinated events which involve two
electron transfers interspersed by the binding of a dioxygen molecule
to the heme iron1-3 (species [2]−[5], Scheme 1). As a result, the
transient peroxo-ferric complex [5a] is formed, which is readily
protonated to form a hydroperoxo-ferric intermediate [5b], often
termed Compound 0. The evaluation of electronic structure of these
iron−oxygen intermediates and of the pathways for proton delivery is
at the heart of understanding how Nature can utilize atmospheric
dioxygen for controlled biological oxidations.

Journal of Physical Chemistry A, Vol 112, No. 50 (December 18, 2008): pg. 13172-13179. DOI. This article is © American
Chemical Society and permission has been granted for this version to appear in e-Publications@Marquette. American
Chemical Society does not grant permission for this article to be further copied/distributed or hosted elsewhere without
the express permission from American Chemical Society.

2

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

Scheme 1

The properties of (hydro)peroxo-ferric intermediates on the path
of oxygen activation in heme and nonheme systems are the subject of
continuing interest in inorganic chemistry and biochemistry.4-9 By using
X-ray crystallography and multiple spectroscopic methods, a great
amount of information has been obtained on the series of mononuclear
nonheme iron complexes where a (hydro)peroxide is coordinated in an
end-on (η1) or side-on (η2) fashion. In particular, the results of
resonance Raman (RR) spectroscopic studies revealed the essential
role played by the spin state of Fe3+ in the strength of Fe−O and O−O
bond strengths in the peroxo/hydroperoxo-ferric complexes.4,10-15
Recently, considerable progress has been achieved in characterization
of similar intermediates in heme proteins obtained by using radiolytic
reduction of the oxy-ferrous precursor frozen at cryogenic
temperatures. Application of EPR, ENDOR, and Mössbauer
spectroscopy provided detailed information on the structure and
stability of these complexes in Hb, Mb, P450, and HO and on the
variety of protonation pathways and reactivity of these
intermediates.16-24 Several high-resolution X-ray structures of peroxo
and hydroperoxo intermediates were also recently obtained by using
cryogenic radiolysis, highlighting the importance of active-site details
(including solvent) in the transformation of these intermediates.25-28
Detailed understanding of the mechanism of formation of [5a] and
[5b] and their role in heme enzyme catalysis is also supported by
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many advanced theoretical studies,29-34 which provide a consistent
framework for the general picture of oxygen activation in heme
enzymes.
Although a great deal of information is available on the role of
iron and porphyrin in the stepwise reduction of dioxygen and on the
specific role of sequential protonation steps of the distal oxygen atom
of coordinated dioxygen, there is still a considerable lack of
information in heme enzymes on the properties of the reduced
dioxygen moiety itself, [5a] and [5b], Scheme 1. Theoretical
calculations predict a significant lengthening of the O−O bond in [5a]
as compared to the oxy-ferrous complex [4] and a further increase in
O−O distance in [5b].29-34 These predictions were supported
qualitatively by the recent structures of [5a] in Mb27,28 and [5b] in
CPO.26 Note that the resolution of these X-ray structures was not high
enough to distinguish between [5a] and [5b], and the assignment of
protonation state of peroxo/hydroperoxo moiety in these works was
based on additional quantum chemical modeling. However, these
structures cannot be directly compared because they are obtained in
different proteins with different axial ligands trans to the coordinated
peroxide, His in Mb and Cys in CPO.
The use of an active-site mutant of cytochrome P450 CYP101, in
which proton delivery is hampered, provides a unique opportunity to
isolate the unprotonated peroxo-ferric intermediate. As a result, a
definitive comparison of Fe−O−O− and Fe−O−OH fragments is made
possible in the present work, wherein we report the first RR study of a
cryoreduced oxyferrous complex prepared in the D251N mutant of
CYP101. Because the first proton delivery in this mutant is
perturbed,17,35-39 the unprotonated peroxo-ferric intermediate [5a] is
observed as the primary species after radiolytic reduction of the oxycomplex in the presence of the substrate camphor at 77 K.17 Because
camphor hydroxylation in this mutant is fully coupled, although much
slower,35,36 and the hydroperoxo-ferric complex [5b] was identified by
EPR and ENDOR after annealing of [5a] at 180 K,17 this system
represents an ideal opportunity to monitor directly the changes in
Fe−O and O−O bonds caused by the first protonation event and to
study both peroxo-ferric [5a] and hydroperoxo-ferric [5b]
intermediates by using cryogenic RR spectroscopy.
Journal of Physical Chemistry A, Vol 112, No. 50 (December 18, 2008): pg. 13172-13179. DOI. This article is © American
Chemical Society and permission has been granted for this version to appear in e-Publications@Marquette. American
Chemical Society does not grant permission for this article to be further copied/distributed or hosted elsewhere without
the express permission from American Chemical Society.

4

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

Methods
Mutation of CYP101, expression of the mutant D251N CYP101 in
E. coli, and purification were performed as described.40 Mutagenesis of
the CYP101 gene (pCamT7) was performed by using the Stratagene
Quikchange kit following the manufacturer’s recommendations.
Mutations were confirmed through sequencing of the entire CYP101
gene (ACGT, Wheeling, IL). In order to construct the CYP101 gene
with the N-terminal hexahistidine tag (pT7-P450 His), the ends of the
gene were modified by using PCR to introduce new restriction cites
(Nde 1 and Hind III), and the resulting gene was cloned into pET28(a)
vector (Novagen, Madison, WI). Protein was expressed in BL21 (DE3)
cells (Stratagene, La Jolla, CA) grown overnight in the presence of 0.5
mM δ-aminolevulinic acid. After cell sonication, resuspension in 50 mM
KPi pH 7.4, 150 mM KCl (buffer A), and ultracentrifugation, the protein
extract was loaded on a Ni-NTA column (Amersham, Piscataway, NJ),
washed with buffer A in the presence of 50 mM imidazole, and eluted
with the same buffer supplemented with 20 mM EDTA. The resulting
red fractions were dialyzed in 50 mM KPi, 400 μM d-camphor, 20 mM
β-mercaptoethanol, pH 7.4 (designated as RB buffer) overnight at
4 °C. Solid ammonium sulfate was added to 30% saturation over 30
min, and the protein was subsequently loaded onto a PhenylSepharose CL6B column equilibrated in the same buffer and eluted in a
linear gradient from 30 to 0% ammonium sulfate. Resulting fractions
with an Rz value (A391/A280) greater than 1.45 were judged as pure and
concentrated by using an Amicon cell.
All samples for Raman and UV−vis spectroscopy contained 100
mM KPi pH 7.4, 100 mM KCl, and 0.6 mM d-camphor. Samples of oxyferrous CYP101 for the RR spectroscopy were prepared as described
previously41,42 with the minor modifications listed below. Concentrated
solutions of ferric CYP101 were deaerated under a stream of Ar gas,
mixed with the degassed 9:1 v/v mixture of glycerol and 1 M
phosphate buffer in an anaerobic chamber (Coy Laboratory Products,
Grass Lake, MI) to the final glycerol/buffer ratio 3:7 v/v, and placed
into the 5 mm NMR glass tubes (Wilmad LabGlass, Buena, NJ). CYP101
was reduced by anaerobic addition of a small molar excess of
dithionite by using a solution of known concentration, determined
spectrophotometrically by using a molar absorption coefficient ε315 =
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8050 M−1cm−1. Complete reduction was verified by absorption
spectroscopy. Oxygenation of the ferrous CYP101 samples was done
directly in NMR tubes connected to the Schlenck line at 4 °C by
sequential application of vacuum, high purity argon, vacuum, and then
16
O2 or 18O2 gas followed by quick vortexing to facilitate oxygenation.
Oxygenated samples were immediately frozen in liquid nitrogen to
minimize autoxidative decomposition of oxy-ferrous CYP101.
Samples of oxy-ferrous CYP101 for the UV−vis absorption
spectroscopy were prepared in UV-enhanced methacrylate semimicro
spectroscopic cells (Fisher Scientific, Allentown, PA) as described.43,44
Different concentrations, from 20 to 80 μM, and an optical path length
of 4.3 mm were used for accurate determination of absorption spectra
in the Soret and Q-band regions and for the optimal background
subtraction (see below). To ensure formation of clear transparent
glassy solvent matrix, a high glycerol content, 2:1 v/v, was used as
described previously.43,44 Samples for absorption spectroscopy were
irradiated together with the RR samples to generate the peroxo-ferric
intermediate and illuminated at 77 K for 8−12 min before
measurement in order to bleach the strong absorption from trapped
electrons generated during radiolysis.44 Absorption spectra of all
samples were measured before and after irradiation at different
temperatures in the range 80−200 K by using the homemade cryostat
as described earlier.43,44 The remaining smooth background due to the
radicals generated by radiolysis in the aqueous glycerol solvent matrix
was the same in all samples with different CYP101 concentrations and
could be eliminated by subtraction of the spectrum of the sample with
the lowest concentration of CYP101 from all other spectra taken at the
same temperatures.
Frozen samples of oxy-ferrous CYP101 were irradiated with 4
Mrad of60 Co γ rays at 77 K and a dose rate 0.95 Mrad/hour. X-Band
EPR experiments were performed at the University of Illinois EPR
Resource Center on a Varian E-122 X-Band (9.03 GHz) spectrometer,
by using microwave power of 0.5 mW and modulation amplitude of 5
Gauss at 100 kHz. An Air Products (Allentown, PA) liquid helium flow
system was used for measurements at 15 K.
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The RR spectra were acquired by using a Spex 1269
spectrometer equipped with a Newton EMCCD detector (Model DU971,
Andor Technologies). The 413.1 nm line from a Kr+ laser (Coherent
Innova Model 100-K3) was used to measure spectra of oxygenated
samples before irradiation, whereas the 441.6 nm line provided by a
He−Cd laser (Liconix Model 4240) was used for probing the irradiated
and annealed samples. The RR spectra were collected by using a back
scattering (180°) geometry with the laser beam (power of 1.0 mW or
less) being focused by a cylindrical lens to form a line image on the
sample. All measurements were taken at 77 K. The frozen samples
were contained in 5 mm o.d. NMR tubes (WG-5 ECONOMY, Wilmad).
The NMR tubes were positioned into a double-walled quartz lowtemperature cell of in-house design filled with liquid nitrogen. The
sample tubes were spun to avoid local heating by the laser beam.
Spectra were calibrated with fenchone and processed with Grams/32
AI software (ThermoGalactic, Salem, NH).

Results
In order to document the changes of the Fe−O−O moiety in the
key iron−oxygen intermediates of P450 catalysis, we have prepared
intermediates [4], [5a], and [5b] in the D251N mutant of CYP101 and
studied these complexes by using RR spectroscopy. As described
earlier,17,18 the cryogenic radiolytic reduction of oxy-ferrous complex
[4] in this mutant CYP101 results in the formation of the unprotonated
state [5a], which is stable at 77 K and undergoes protonation to afford
[5b] after brief annealing above 180 K. By using cryogenic Raman
spectroscopy, we have measured the RR spectra of these
intermediates before and after protonation and assigned the positions
of ν(O−O) and ν(Fe−O) modes. The protonation state of both
intermediates [5a] and [5b] was confirmed by the EPR spectroscopic
signatures of these states before and after annealing at 185 K,
respectively. Both EPR and Raman data sets were obtained by using
the same samples, to ensure the proper assignment of the
spectroscopic results. In addition, the UV−vis absorption spectra of
complexes [4], [5a], and [5b] are also reported herein.
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A Electronic and EPR Spectroscopy
We measured EPR spectra on the same samples used in the
Raman experiments, both before and after Raman measurements, to
confirm formation of the peroxo-ferric complex [5a] in CYP101
immediately after irradiation at 77 K and to monitor protonation of this
intermediate and formation of the hydroperoxo-ferric complex [5b]
after annealing at 185 K. As shown in Figure 1A, X-band EPR spectra
of the cryoreduced oxy-ferrous D251N mutant of CYP101 measured
after irradiation displayed a low-spin rhombic species with g-values
[2.245, 2.16, 1.95] diagnostic of an unprotonated ferric-peroxo moiety
with end-on (η1) geometry, in agreement with the earlier Q-band EPR
studies of the same mutant in CYP101.17 After annealing to 185 K, an
almost complete conversion to the protonated ferric peroxo species
with g-values [2.29, 2.17, 1.95] is observed (Figure 1A), again
confirming earlier results.17

Figure 1. (A) EPR spectra of the reduced oxy-ferrous complex of D251N CYP101. Data
measured after irradiation at 77 K and after all RR experiments and annealing at 185
K. The hydrogen atom doublet is marked by the star sign. Vertical bars indicate the
features of peroxo-ferric (upper line) and hydroperoxo-ferric (bottom line) complexes
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with the corresponding g-values. Frozen samples are in 100 mM phosphate (H2O or
D2O, as indicated), 100 mM KCl, 30% glycerol v/v, T = 15 K. Other details of EPR
spectroscopy are described in Methods. (B) Absorption spectra of D251N CYP101: (1)
Oxy-ferrous complex, T = 85 K, before irradiation; (2) peroxo-ferric complex, 90 K,
after irradiation at 77 K; and (3) hydroperoxo-ferric complex, 180 K, after irradiation
at 77 K and annealing at 185 K. Frozen samples are in 100 mM phosphate (H2O), 100
mM KCl, pH 7.4, 65% glycerol.

The transitions in protonation state of the cryoreduced oxy P450
mutant are similarly reflected in low-temperature optical spectroscopy
experiments (Figure 1B), with the spectrum of the parent,
nonreduced, dioxygen adduct being shown for reference. The features
of the absorption spectrum of the reduced oxy-ferrous complex of the
mutant protein at 90−120 K in both the split Soret band (main
maximum at 439 nm with the second one at 361 nm) and Q-band (α
and β bands at 561 and 530 nm, respectively) are similar to those
obtained in analogous experiments with the CYP101 reported
earlier.43,44 Upon annealing from 90 to 180 K, the Soret band shifts to
437 nm, and the second band shifts to 365 nm, indicating the
decreased splitting in [5b] as compared to [5a] with only minor
changes observable in intensities of the Q bands. These small changes
are consistent with the protonation of [5a] and formation of the
hydroperoxo-ferric intermediate [5b].17

B RR Spectroscopy
RR spectroscopy is the most powerful method for providing
direct information about Fe−X−Y bond strengths and, through the
observation of hydrogen−deuterium isotope shifts of corresponding
vibrational modes, reveals important details concerning the
protonation state of H/D-exchangeable groups, such as the peroxoferric fragments of interest here. In this work, we present the RR
characterization of the precursor dioxygen adduct [4] and each of the
cryoreduced forms [5a] and [5b].

1 Dioxygen Adduct(s) of D251N
Two series of isotopically (16O2 and 18O2) labeled samples of
D251N were prepared in H2O and D2O buffers, and their RR spectra
were collected before irradiation in order to establish the vibrational
signature of this oxygenated precursor and to document successful
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isotopic labeling. The high frequency RR spectrum of oxygenated
D251N is shown in trace A of Figure 2. This spectrum resembles that
already published earlier by Sjodin et al.,45 with a strong, slightly
broadened, band centered near 1134 cm−1 that is attributable to bands
associated with the ν(16O−16O) stretching mode. As was pointed out in
earlier work,45 this broadened band is most reasonably interpreted to
reflect the existence of two or three structural conformers of the
Fe−O−O fragment. It was concluded45 that for both the wild-type (WT)
and D251N oxygenated proteins, there is one major conformer
exhibiting its ν(16O−16O) at 1138 or 1136 cm−1, respectively, with both
proteins having two minor conformers detected at 1146 and near 1130
cm−1. Interestingly, it was also shown that upon binding of its reduced
electron transfer partner putidaredoxin (Pd) to the D251N mutant, the
1129 cm−1 component was populated to an extent nearly comparable
to the 1137 cm−1 species; that is, two nearly equally intense bands
were observed.45

Figure 2. High-frequency RR spectra of oxy D251N CYP101 measured at 77 K and
difference spectra before irradiation (excitation at 413 nm). Inset shows low-frequency
difference spectra of 16O2−18O2 in H2O (A) and in D2O (B) buffer.
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As will be discussed, our new data acquired at 77 K not only
support this previous suggestion of multiple conformers but reveal the
fact that the difference in the two major conformers appearing at 1136
and 1125 cm−1 at 77 K is associated with changes in H-bonding. Thus,
careful inspection of the spectra (traces B and C of Figure 2) reveals
the existence of two isotope-sensitive modes, the vibrational
parameters of which can be extracted by fitting the difference traces
with 50/50 Gaussian/Lorentzian profiles. It was found that the broad
positive feature centered at around 1134 cm−1, as well as the negative
one centered at around 1065 cm−1 in trace B, had apparent
bandwidths of 22−23 cm−1, whereas the relatively isolated heme
mode, ν4, appearing at 1373 cm−1, had a bandwidth of 12 cm−1. Not
surprisingly, the best fit of those isotope-sensitive features is achieved
by using two functions that had 11−12 cm−1 bandwidth, yielding two
modes at 1136 and 1125 cm−1 exhibiting 66 and 65 cm−1 shifts upon
18
O2 substitution, respectively, in agreement with that predicted by
Hooke’s law. Moreover, the results obtained with the samples prepared
in deuterated solvent show that the lower frequency ν(O−O) stretch
exhibits a clear 2 cm−1 upshift upon D2O exchange, which suggests
that the lower frequency conformer is in fact participating in a
hydrogen bonding interaction with a distal side residue apparently
different than that corresponding to the higher-frequency conformer.
It is important to emphasize that in the spectra of oxygenated WT
CYP101 at 77 K, only one strong ν(O−O) stretch was detected at 1139
cm−1, which also failed to exhibit an H/D shift.42 Thus, the present
work shows that the population of this type of second conformer
actually occurs merely by lowering the temperature of the oxygenated
D251N mutant to 77 K and does not require binding of Pd.45
The lower frequency of the proposed H-bonded form is
consistent with early work with model compounds where, by
comparing ν(O−O) stretching frequencies of dioxygen adducts of
pyridine ligated CoTPP with those of corresponding picket-fence
derivatives, it was demonstrated that the picket-fence adducts
exhibited significantly (up to 5 cm−1) lower frequencies, a shift that
was reasonably attributed to H-bonding interactions with the amide
linkages of the picketfence fragments.46 Furthermore, in recent RR
studies of dioxygen ligated NOS isoforms, shifts of precisely this
magnitude have been attributed to H-bonding differences; that is, the
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substrate-free dioxygen adduct exhibited a ν(O−O) at 1133 cm−1,
whereas that of the arginine-bound form was observed at 1126 cm−1.47
By referring to the sensitivity to deuterium substitution,
although H/D induced 2−5 cm−1 shifts to higher frequency of the
ν(O−O) modes of dioxygen adducts of cobalt-substituted globins have
been plausibly attributed to D- versus H-bonding interactions,48 it has
been demonstrated that such interpretations are potentially
compromised by complications arising from unusually strong
vibrational coupling interactions between the ν(O−O) mode and
internal modes of the trans-axial histidyl imidazole, the coupling
patterns changing as the latter modes shift in response to H/D
exchange at the imidazole H−N fragment.49-51 In the present case,
however, the absence of the trans-axial imidazole obviates
consideration of such complications, and the 2 cm−1 upshift can
reasonably be attributed to H-bonding; in fact, a recent RR study of
dioxygen adducts of cytochrome P450 model compounds, in which
hydroxyl groups were incorporated into the distal pocket to serve as
H-bond donors to the bound dioxygen, the ν(O−O) band indeed
displayed an identical 2 cm−1 shift to higher frequency upon H/D
exchange of the distal pocket hydroxyl groups.52
The low frequency spectra of oxygenated D251N samples
(Figure 2, inset) exhibit a feature in the ν(Fe−O2) stretching region at
537 cm−1 that shifts down by 30 cm−1 upon 18O2 substitution. On the
basis of the observation of two ν(O−O) modes in the high-frequency
region, it might have been expected that two ν(Fe−O) modes would be
observed in the low-frequency region. Owing to the relatively low S/N
ratio seen here, however, no significant broadening is discernible, and
no clear H/D shift is detected (Table 1). Such H/D shifts, if present,
are indeed expected to be quite small and are not normally observed
for these low-frequency ν(M-O2) modes.45,53-56 Although we have
obtained no clear evidence for separation of the ν(Fe−O) region into
two distinct features, similarly to earlier results,45 we note the
presence of the positive correlation between the ν(Fe−O) and ν(O−O)
modes. The presence of a lower-frequency ν(O−O) mode at 1125 cm−1
is correlated with an apparent shift to lower frequency for the
observed ν(Fe−O) mode(s) from 546 to 537 cm−1.
Table 1. Frequencies of Isotopically Sensitive Modes of WT and D251N
Mutant of CYP101 and their Isotopic Shifts (Spectra Measured at 77 K)
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frequency and isotopic shift [cm−1]
ν(Fe−O) Δ[16O2/18O2; H2O/D2O]

ν(O−O) Δ[16O2/18O2; H2O/D2O]

WT

a

Fe(II)−O2 [4]

546 [31 ; 0]

1139 [66 ; 0]

Fe(III)−O22− [5a]
Fe(III)−O2H− [5b]

559 [27 ; 3]

799 [40 ; 3]
D251N

Fe(II)−O2 [4]

537 [30 ; 0]

1136 [66 ; 0] 1125 [65 ; +2]b

Fe(III)−O22− [5a]

553 [27 ; 0]

792 [38 ; 0]

Fe(III)−O2H [5b]

564 [28 ; 2]

774 [37 ; 4]

−

Data from ref 42.
Plus sign indicates shift to higher frequency, opposite to the normally observed
direction.
a

b

2 Irradiated and Annealed Samples of OxyD251N
The RR spectra of irradiated oxyD251N samples show two
isotopically sensitive species (Figure 3). The mode observed in the
spectra of 16O2 in H2O at 553 cm−1 shows a 27 cm−1 down shift upon
18
O2 substitution. The other isotopically sensitive mode at 792 cm−1
exhibits the expected 38 cm−1 down shift upon 16O2/18O2 exchange
(Table 1). Most importantly, neither of these modes exhibit H2O/D2O
sensitivity, an observation most consistent with the assignment of
these features to the ν(Fe−O) (at 553 cm−1) and ν(O−O) (at 792
cm−1) modes of a peroxo species. Note that distinct H/D shifts have
been documented for these modes for the hydroperoxo intermediate of
the WT protein.42 This is the first direct observation of the vibrational
frequencies of the nonprotonated peroxo intermediate [5a] of a
member of the cytochrome P450 protein family, and its assignment is
consistent with earlier EPR and absorption spectroscopic studies.17,18
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Figure 3. RR spectra of irradiated P450 D251N samples in H2O buffer, spectra A
(16O2) and B (18O2), and in the D2O buffer, spectra C (16O2) and D ((18)O2). The two
bottom traces shows the difference spectra of 16O2−18O2 in H2O and 16O2−18O2 in D2O
buffer (excitation line 442 nm, temperature 77 K).

Earlier, it was shown that annealing of such irradiated samples
to higher temperatures (above 170 K) allows protonation of this
peroxo species to yield the hydroperoxo form.17,18 Consistent with this
picture, the spectra of our samples annealed to 185 K and then cooled
to 77 K for RR measurements are presented in Figure 4 and document
a difference pattern of isotopically sensitive modes that is similar to
that observed before annealing but which reveals distinctly different
component frequencies. The mode appearing at 564 cm−1, seen in the
trace A of Figure 4, exhibits a 28 cm−1 downshift upon 18O2 substitution
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frequency mode at 774 cm−1 shifts down by 37 and 4 cm−1 upon 18O2
and H/D exchange, respectively (Table 1). Those H/D shifts are in a
good agreement with previously published RR data for known metallohydroperoxo species4,41,42,57 and are consistent with the hydroperoxo
formulation derived from EPR and UV−vis data for annealed samples
of irradiated D251N.17 Clearly, the modes at 564 and 774 cm−1 are
most reasonably assigned as the ν(Fe−O) and ν(O−O) modes of the
hydroperoxo-ferric species [5b], respectively.

Figure 4. RR spectra of irradiated and annealed at 185 K samples of P450 D251N in
H2O buffer, spectra A (16O2) and B (18O2), and in the D2O buffer, spectra C (16O2) and
D (18O2). The two bottom traces shows the difference spectra of 16O2−18O2 in H2O and
16O −18O in D O buffer (excitation at 442 nm, temperature 77 K).
2
2
2

Further annealing to higher temperatures (195 and 205 K) did
not lead to the observation of any new isotopically sensitive modes, at
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least when employing the 442 nm excitation line used here for the
peroxo/hydroperoxo forms (Figure S1, Supporting Information).
Future work, employing higher concentrations, different excitation
lines, and other solution conditions, including the use of different
substrates, will be conducted in order to search for these later, highly
reactive intermediates.

Discussion
In this study, we document the changes in the Fe−O−O moiety
monitored by RR spectroscopy in the key intermediates of dioxygen
activation in the cytochromes P450. The isolation and separate
spectroscopic studies of unprotonated peroxo-ferric and protonated
hydroperoxo-ferric complexes [5a] and [5b] have been made possible
by using the D251N mutant of CYP101, which yields exclusively [5a]
as a results of cryogenic radiolytic reduction of [4].17,18 The
protonation states of [5a] as prepared at 77 K and of [5b] after
annealing at 185 K have been assigned by using characteristic EPR
signature spectra, measured on the same samples used for the Raman
spectroscopy. As a result, we can compare for the first time the
vibrational modes ν(O−O) and ν(Fe−O) measured for [4], [5a], and
[5b] on the same sample to evaluate the effects of the one-electron
reduction and of protonation on the structure and stability of these
intermediates of dioxygen activation.
The RR spectra of the dioxygen adduct [4] of the D251N protein
show small but distinct differences from the corresponding spectra of
the WT protein.42 The D251N adduct exhibits two relatively strong
ν(O−O) stretching modes at 1136 and 1125 cm−1, whereas the WT
shows only one intense mode near 1139 cm−1. Neither the 1136
(D251N) nor the 1139 cm−1 (WT) features are sensitive to H/D
exchange, but the 1125 cm−1 mode of the mutant exhibits a distinct 2
cm−1 shift to higher frequency in the deuterated solutions (Figure 2),
implying that one effect of the D251N mutation is to facilitate
substantial population of a second conformer, a result in agreement
with more recent crystallographic data.58 Although early
crystallographic studies of the oxygenated complex of the D251N
mutant did not show multiple conformers,59 more recent work
indicates that two conformations of the Asn251−Thr252 region of the
Journal of Physical Chemistry A, Vol 112, No. 50 (December 18, 2008): pg. 13172-13179. DOI. This article is © American
Chemical Society and permission has been granted for this version to appear in e-Publications@Marquette. American
Chemical Society does not grant permission for this article to be further copied/distributed or hosted elsewhere without
the express permission from American Chemical Society.

16

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

protein are present in crystals of the dioxygen adduct of D251N
CYP101.58
The frequencies of the ν(O−O) and ν(Fe−O) modes for all
species detected here and in the previous study of the hydroperoxo
form of the WT protein are collected in Table 1. As mentioned,
cryoradiolysis of the oxygenated WT protein at 77 K yields directly the
hydroperoxo derivative [5a], the ν(O−O) and ν(Fe−O) modes of which
appear at 799 and 559 cm−1, respectively, both exhibiting telltale
shifts to lower frequency in D2O solutions.42 Given that the most
significant effect of the D251N mutation is to restrict proton delivery to
the initially formed ferri-peroxo fragment, it is not surprising that, as
shown previously,17,18 this species is trapped at 77 K and, as shown
here, exhibits ν(O−O) and ν(Fe−O) modes at 792 and 553 cm−1,
neither of which shows any sensitivity to H/D exchange. This strongly
suggests that these modes refer to the peroxo-ferric intermediate
[5a]. The hydroperoxo derivative of D251N [5b], formed upon
annealing to higher temperatures, exhibits a substantially lowerfrequency ν(O−O) mode at 774 cm−1 and a significantly higherfrequency ν(Fe−O) mode (i.e., 564 cm−1) compared to its
nonprotonated precursor. By assuming that a similar (18 cm−1) shift of
ν(O−O) for transition between [5a] and [5b] occurs for the WT
protein, the estimated frequency for the unobservable reactive peroxoferric [5a] derivative of WT CYP101 would be ∼817 cm−1, that is, 799
+ 18 cm−1. On the basis of this estimated frequency for the [5a] form
of the WT protein, the shift in ν(O−O) upon conversion from peroxo to
hydroperoxo forms for both proteins would be 18 cm−1, and the
observed shifts in comparing similar forms of both proteins are 25
cm−1. For both the [5a] and [5b] states, ν(O−O) in the mutant is 25
cm−1 lower than that in the WT protein. Thus, not only does the
mutation retard proton delivery to the Fe−O−O− fragment, but the
replacement of Asp251 acid side chain with amide also leads to
substantial active-site differences that significantly affect the
disposition of the Fe−O−O structure, as reflected in the downshift of
ν(O−O) vibrational mode. These shifts to lower frequency for the
reduced forms of the D251N mutant relative to the WT protein are also
consistent with the increased stabilization of the lower-frequency
conformer of the parent form [4], the 1125 cm−1 component of which
was shown to be much more highly populated in the mutant,
Journal of Physical Chemistry A, Vol 112, No. 50 (December 18, 2008): pg. 13172-13179. DOI. This article is © American
Chemical Society and permission has been granted for this version to appear in e-Publications@Marquette. American
Chemical Society does not grant permission for this article to be further copied/distributed or hosted elsewhere without
the express permission from American Chemical Society.

17

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

compared to the WT CYP101, at least at 77 K. Although it had been
shown previously that at 4 °C, the higher-frequency conformer
dominates the spectra for both the WT and D251N mutant,45 the
results obtained here clearly show that the lower-frequency conformer
is substantially populated at 77 K but only in the case of the mutant.
Thus, although the H-bonded conformer is more easily accessed in the
case of the mutant, its population is significant only at low
temperatures. Such structural changes at cryogenic temperatures
have been previously documented in EPR studies of single crystals of
oxygenated cobalt myoglobin60 and in RR studies of deoxy hemoglobin,
where significant increases in the frequency of the ν(Fe−Nhis)
stretching mode, associated with the linkage to the proximal histidine,
were reasonably attributed to thermal contraction that stabilizes
certain key interactions.61
Collectively, the data presented in Table 1 provide the first clear
opportunity to directly compare experimental vibrational data for these
superoxo/peroxo/hydroperoxo heme derivatives in similar
environments. In CYP101, upon reduction from [4] to [5a], there is a
large shift of ν(O−O) from ∼1135 cm−1, characteristic of bound
superoxide, to ∼800 cm−1, a frequency indicative of a bound peroxofragment. At the same time, the observed ν(Fe−O) mode shifts to
higher frequencies by ∼15 cm−1, for example, 537 to 553 cm−1.
Protonation to yield the hydroperoxo derivative causes the ν(O−O) to
decrease by 18 cm−1, whereas the ν(Fe−O) simultaneously increases
by 11 cm−1 to 564 cm−1. As can be seen by inspection of Table S1
(Supporting Information), where the results of several computational
studies are summarized, the predicted changes in vibrational
parameters in proceeding from the parent [4] through the [5a] and
[5b] intermediates are generally consistent with those observed here.
An exception is the behavior of the ν(Fe−O) modes in proceeding from
[4] to [5a], where strengthening of this bond is evident from the
vibrational data, whereas a weakening (longer bond) is predicted from
all of the calculations. However, it is particularly satisfying to note that
virtually all computational work correctly predicts the anticorrelation,
involving increased Fe−O and decreased O−O bond strengths upon
formation of the hydroperoxo intermediate. The weaker O−O bond in
[5b] can be rationalized in terms of the higher electron density on the
dioxygen moiety filling the antibonding π* orbital of hydroperoxide in
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[5b], as compared to unprotonated [5a]. This is consistent with the
overall lower spin density on the distal and proximal oxygen atoms in
[5b] than in [5a] as suggested on the basis of the proton ENDOR
measurements,17 as well as with the similar predictions of DFT
theoretical studies.29-34
In conclusion, we have documented the vibrational
characteristics of the Fe−O−O moiety in the main intermediate states
of oxygen activation by the cytochromes P450. By using the D251N
mutant of CYP101, we have prepared the oxy-ferrous complex [4] and
used cryogenic radiolytic reduction at 77 K followed by annealing at
185 K to isolate peroxo-ferric and hydroperoxo-ferric intermediates
[5a] and [5b]. By using cryogenic Raman spectroscopy, we have
identified for the first time both the ν(Fe−O) and the ν(O−O)
stretching modes in all three iron−dioxygen intermediates and
evaluated experimentally the influence of reduction and protonation on
the changes in Fe−O and O−O bond strength. Reduction of [4] and
the concomitant formation of peroxo-ferric complex [5a] result in
significant weakening of the O−O bond, indicating transition from
superoxo to peroxo electronic structure. Further weakening of O−O
bond is caused by protonation of the distal oxygen atom in [5b],
consistent with the predictions of theoretical studies. Contrary, the
Fe−O bond is becoming stronger during the transition from [4]
through [5a] and to [5b], revealing the presence of the negative
correlation between ν(Fe−O) and ν(O−O). As the first available set of
vibrational characteristics of Fe−O−O intermediates, our data provide
further insight into the mechanism of oxygen activation in heme
enzymes, as well as the convenient benchmark for the refinement of
the detailed quantum chemical calculations.
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